Page 1804, column 1, section 5.3.1, paragraph 2, which previously read:
''Significantly [12] or numerically [11, 54] more patients in the linagliptin than in the placebo groups achieved an HbA 1c level of B7.0% (table IV) [11, 12] or \6.5% (10% vs 2%; OR 5.5; p \ 0.0016), [12] a reduction in HbA 1c of C0.5% (table IV) [12, 54] or required rescue therapy (8% vs 19%; OR 0.28; p = 0.0001).
[12] '' Should read:
''Significantly [12] or numerically [11, 54] more patients in the linagliptin than in the placebo groups achieved an HbA 1c level of B7.0% (table IV) [11, 12] or \6.5% (10% vs 2%; OR 5.5; p \ 0.0016) [12] or a reduction in HbA 1c of C0.5% (table IV) , [12, 54] and significantly fewer linagliptin than placebo recipients required rescue therapy (8% vs 19%; OR 0.28; p = 0.0001).
[12] ''
